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Summary: We developed a candidate reference method for the determination of creatinine in seaim. For the 
acceptance of a reference method it is important that it be rigorously validated against a definitive method and that 
the method can be transferred from one laboratory to another.
This study focussed on the transferability and consisted of two parts: introduction and familiarization with the 
method in four clinical chemistry laboratories in the Netherlands, followed by independent measurements of Stan­
dard Reference Material 909a2 and several commercial quality control materials provided with reference method 
values according to the protocol of the German Quality Assessment Organisation.
The criterion for judging transferability was the mean total error (%) of the five sera used in the accuracy experi­
ment. For creatinine we used a total error of <  2.2%. For Standard Reference Material 909a2 all four laboratories 
were able to comply with this demand, while only two laboratories met this requirement for the other four sera.
The results for the Standard Reference Material 9G9a2 from the collaborating laboratories demonstrate that this 
candidate reference method can be successfully transferred without loss of precision and accuracy.
introduction
In earlier papers Zwang et al. described various method­
ological aspects of a HPLC-based procedure for measur­
ing creatinine in serum (1, 2). Since then, this selected 
method has been used in many clinical studies and for 
target setting of materials used in external quality as­
sessment programmes.
During four years the stability of the method was as­
sessed by using serum samples 909al and 909a2 (Stan­
dard Reference Material) obtained from the National In­
stitute of Science and Technology (USA). In table 1 the 
results are given for the use of various columns and 
filters (batches, types), as well as the most recent results
W
obtained with the same column and filter type.
The latter combination was tdso used in a limited com­
parison study with human serum samples using the de­
finitive method of the Central Reference Institution of 
the German Society for Clinical Chemistry. The data are 
elaborated according to the statistical procedure de­
scribed by Bland  & Altmann (3) and depicted in figure 1.
These favourable results prompted us to study the trans­
ferability of our method.
Transferability of a method implies that the method can 
be successfully applied in other laboratories based on
specifications and procedures as described in the origi­
nal method implementation.
Therefore three other Dutch laboratories, well experi­
enced in routine high performance liquid chromatogra­
phy (HPLC) determinations, were asked to evaluate in­
terlaboratory transferability.
The transferability study was organized according to the 
guidelines of a multicentre study, i.e. with extensive
Tab. 1 Measurement o f  serum creatinine concentrations in SRM 
909a 1 and SRM 909a2 in laboratory A.
Period N  Creatinine (jmol/I)
Mean SD CV
(%)
SRM 9 0 9 a la 1991 —*95 137 82.1 1.2 1.4
SRM 909a2 1991 - '9 5 167 458.9 5.9 1.3
SRM g o g a i1’ 1994— ’95 2 2 82.4 1.0 12
SRM 909a2 1994— *95 52 464.7 3.7 0.8
Remarks
a Experimental design changed from 15 cm columns to 5 cm col­
umns with slightly modified ion-exchange material. Also the ultra- 
filters were from several manufacturers and the cut-off calues var­
ied from Mv 10000 to Mr 30000.
b In this series only the 5 cm ion-exchange colum was used to­
gether with the M r 30 000 filter unit.
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In all German survey samples creatinine determinations were per­
formed by isotope dilution-mass spectrometry (1DMS) as described 
by Siekmann et al. and by a validated reference method (5 -7 ) .
M e th o d s  
Ultra filtration
In this study Ultracent 30,000D (Bio-Rad Laboratories, Hercules, 
USA) was used instead of the Ultracent 10,000D. Ultracent 
3O,O0OD produces ultrafiltrate in a centrifuge with a swing-head
rotor (60 min at 2900 £■)•
Adjustment for the volume displacement effect due to serum pro­
teins was made according to Weast (8).
100 200 300 400 500 600 700 Sample pretreatment
Creatinine (average (1DMS,HPLC)) [pmol/l]
Fig. 1 Comparison o f  the method with isotope dilution-mass 
spectrometry (IDMS) for ten hum an sera. Mean difference 0,69 
Hmol/1, dashed lines 2 SD limits. Standard error of the mean 1.054 
j.imol/1, dotted lines 95% confidence interval S, E. M,
Serum samples of 500 jliI were ultrafiltered for 60 minutes at 
2900 g, and 10 \x\ aliquots o f  the ultrafiltrates were directly injected 
into the HPLC system. The ultrafiltrates were analysed in triplicate.
Total protein determination
Total protein was determined by a biuret procedure, calibrated 
against the reference method (9).
consideration of the methodological aspects beforehand, 
followed by an initial trial and finally a main trial (4). High performance liquid chromatography (HPLC) 
The Rotterdam laboratory was appointed as core labora­
tory.
Materials and Methods
M a te r i a l s
All laboratories used the same 50 X 4.6 mm (i.d.) modified weak 
cation-exchange column, column numbers 18056—18066, from 
Bio-Rad, Veenendaal, The Netherlands, as described by Zwang et 
al. (2). Columns were thermostated at 40 °C. The flow rates in the 
initial trial were 1,0 or 1.5 ml/min; in the final experiments 1.0 ml/ 
min was chosen,
Participants applied their own HPLC-configurations,
Chemicals were essentially the same as in our previous study (1). -  Laboratory A used the HPLC system as described in I.e. (1),
For calibration we used Standard Reference Material 914a from the 
National Institute o f  Standards and Technology (Gaithersburg, 
USA).
The stock solution o f  creatinine was prepared in class A glassware, 
in an approximate concentration o f  5000 p n o l/ l .  In the initial trial, 
all laboratories used the same stock solution made by laboratory 
A. In the final study, all laboratories made their own stock solution. 
The stock solutions are used to prepare six aqueous standard solu­
tions, all in class A glassware with class A  volumetric pipettes, 
covering the range 50 to 1250 (.tmol/L
Serum samples
The weight o f  the water used for reconstitution of the lyophilized 
sera was taken to calculate the exact volume with connection for 
temperature and pressure. Sera and control material were divided 
into 1 ml aliquots and stored at — SO °C until use. The frozen sam­
ples were distributed to the participating laboratories on dry-ice.
The following sera were used:
a. Testpoint Level 1, lots V 8K 50U  V09316 (L I)  and Level 2 lots 
V8K502, V09317 (L2) were unassayed chemistry control samples 
from Bayer Teehnicon, USA.
b. Hum an serum pools P I and P2.
c. Standard Reference Material (SRM) 909a I and 909a2, National 
Institute of Standards and Technology (Gaithersburg USA).
d. Serum samples as applied in the surveys organized by the 
Deutsche Gesellschaft fur Klinische Chemie (Zentrale Re fere nz in­
stitution):
— Sample KL; Kontrollogen-L, lot no. 623134 Behringwerke AG, 
Marburg, Germany.
— Sample RV, serum sample used in a Germany survey.
— Samples PNU and PPU; Precinonn U, lot No. 182658 and Preci- 
path U, lot No. 181801 Boehringer Mannheim, Mannheim, Ger­
many.
— Laboratory B used a system o f  Hewlett Packard Co., Palo Alto, 
CA, model 1090 M HPLC equipped with an ultraviolet diode-ar- 
ray detector.
— Laboratory C used a system of Thermo Separation Products, 
Fremont, California, USA, pump model AS 2000, autosampler AS 
1000 and a Focus detector,
— laboratory D used a HPLC system of Bio-Rad, Hercules, Cali­
fornia, USA, pump model 1330, autosampler model AS-100 and a 
Chrom-A-scope detector model 1970.
E v a lu a t io n  d e s ig n
The study started with a round robin in order to familiarize partici­
pants with the various technical aspects o f  the study. As a result we 
decided to perform an initial trial before the transferability study.
All laboratories measured the linearity o f  this method on their own 
system, together with within-run and day-to-day imprecision study 
with two unassayed human serum samples and two control sera. 
The linearity test consisted o f  6 aqueous dilutions o f  the creatinine 
stock (50, 100» 250, 500, 750 and 1250 |umol/l creatinine) and all 
concentrations were injected in triplicate.
In the main trial, day-to-day and within-run imprecision studies 
were repeated and accuracy was assessed. For the day-to-day im­
precision the ultrafiltrates of four samples are measured in tripli­
cate on ten working days. The within-run imprecision was deter­
mined on two levels by tenfold injections of two samples. For the 
accuracy study five validated reference sera and triplicate injection 
were used on three different days.
Results
E v a lu a tio n  o f  the  in i t ia l  tr ia l re su lts  
In the initial trial relatively high CV values, both be­
tween and within-run, were seen (tab. 2 and tab. 3).
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Participants were asked to examine their HPLC system 
carefully according to the following points:
-  sample loop: two participants used a full loop and 
two a partially filled loop. For partial injection it is im­
portant that the syringe used in the autosampier is accu­
rate. In the final trial only laboratory B used partial fill­
ing.
-  flow rate: flow rate was set to 1.0 ml/min, as a lower 
flow rate increases peak areas (UV detectors are mass 
transfer-dependent). This is beneficial to the variation 
coefficient, especially at low concentrations of creati­
nine.
-  detector: monitor the stability of the detector. The 
relatively short lifetime of a deuterium lamp (500 — 
1000 h) can cause changes in the peak areas due to fluc­
tuations in the energy of the lamp when the lamp is due 
for replacement.
-  integration parameters: peak areas were used and 
proper integration parameters should be used.
The linearity test performed well in all laboratories: all 
systems were linear up to 1250 juimol/l with a r2 of at 
least 0.9999. Because standard creatinine solutions are 
pure aqueous solutions, we decided to thoroughly exam­
ine the performance of the ion exchange column. Differ­
ences seen during ultrafiltrate analysis were probably 
caused by unwanted coelution o f a late eluting unknown 
component from a preceding injection. As all the partici­
pants used columns from the same batch we used a sim­
ple HPLC optimizing program, fcEmergo’ (Chrompack, 
Bergen op Zoom, The Netherlands), to decide if optimi­
zation of the HPLC conditions for this batch was neces­
sary. The result o f this exercise was an increase of the 
lithium acetate concentration (from 15 mmol/1 to 57.5 
mmol/1) and an increase o f the pH (4.8 to 5.2) of the 
elution buffer.
M ain t r ia l
All laboratories used samples LI and L2 for determina­
tion o f the within-run imprecision. The results are sum­
marized in table 4.
For the day-to-day imprecision we also included Preci- 
path U and Precinorm U. The results are given in 
table 5. The last part consisted of the accuracy study 
with 5 validated serum samples. The numerical results 
of ail measurements are mentioned in table 6 , while 
the total error data are graphically presented in fig­
ure 2 .
Tab. 2 Initial trial day-to-day imprecision of duplicate filtrations measured on ten days in each of the 
four laboratories.
Sample Lab orato 17
A B C D
LI Creatinine [jamol/1], mean 93.1 93.2 89.3 94.1
CV [%] 0 .8 2.4 2.7 3.8
L2 Creatinine [jamol/1], mean 628.7 618.7 604,0 637,2
CV [%] 0.8 1.9 2.1 1.7
PI Creatinine [jimol/1], mean 115.1 114.1 109.1 116.5
CV [%] 0.9 2.1 1.2 3.0
P2 Creatinine [jimol/1], mean 414.2 408.3 393.3 419.1
. CV [%] 0 .6 2.5 1.4 3.7
Tab. 3 initial trial within-run imprecision, with ten-fold filtration o f  all four samples, and HPLC analy­
ses in triplicate.
Sample Laboratory
A B C D
LI Creatinine [fimol/l], mean 92.0 94.0 89.3 93.6
CV [%] 0 .6 1.0 0 .8 2 .0
L2 Creatinine [jimol/1], mean 627.0 621.8 597.3 629.4
CV [%] 0.3 1.1 0 .6 1.6
PI Creatinine [jimol/1], mean 115.1 116.5 107.4
n
CV [%] 0.9 6.4 1.0
a
P2 Creatinine [umol/1], mean 415.8 403.9 393.3
n
CV [%] 0 .6 2.5 1.3
a
a Due to a problem with a column oven laboratory D produced no results.
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Tab. 4 Main trial o f  within-run imprecision, with triplicate filtration o f  LI and L2, and ten HPLC 
analyses o f  the ultrafiltrates.
Sample Laboratory
A B C D All“
LI Creatinine [umol/1], mean 55.9 55.5 56.4 54.9 55.7
CV [%] 0.3 0.6 0.5 6.5
L2 Creatinine [umol/1], mean 332.8 339.5 338.5 332.9 335.9
CV [%] 0.5 0.3 1.1 2.7
Mean o f  means
Tab. 5 Main trial day-to-day imprecision measured on ten days, with single filtration and triplicate 
HPLC analyses on each fíltrate.
Sample Laboratory
A B C D Alla
LI Creatinine [fimol/l], mean 56.3 55.5 56.0 56.2 56.0
CV [%] 1.1 1.2 0.9 6.6
L2 Creatinine [jLunol/1], mean 332.8 336.9 334,6 332.8 334.3
CV  [%] 0.4 i . l L3 1.8
PNU Creatinine [j.tmol/1], mean 164.7 165.1 164.5 165.4 164.9
CV [%] 0.8 0.5 1.0 2.7
PPU Creatinine [j.imol/1], mean 353,2 356.0 352.6 352.3 353.5
CV [%] 0.5 0.9 1.1 L 6
a Mean o f  means
Discussion
The performance of a reference method in clinical chem­
istry implies high-quality analytical tools and personal 
dedication and skill (10—12), Before the beginning of 
this creatinine transferability study, we were convinced 
o f the existence of these preconditions in our group. 
Furthermore, we discussed the organization of the study 
at length and took many precautions. Despite all these 
considerations we failed in the initial trial, due to varia­
tion among the participating laboratories (tabs. 2 and 3). 
The modifications were applied, after discussions with 
all participants, proved to be successful as can be seen 
from tabs. 4 and 5.
The question arises as to whether we succeeded in up­
grading the earlier published selected method to a refer­
ence method. Or in other words as raised by M oran: 
When is a “reference method” a “Reference Method” 
(13)?
An excellent review on the theoretical background of a 
reference method as a basis for accurate measuring sys­
tems is given by Büttner ( 11). Essential requirements 
in relation to the application of a reference method are 
described in this publication. The same holds in a practi­
cal way for a paper published by Thienpont et al. (14).
It is beyond the scope of our study to describe in 
detail all aspects related to reference methodology. 
High performance liquid chromatography is well ac­
cepted for the determination of creatinine (15, 16). 
We intended to focus on an important element, i.e. 
transferability. This meant that we had to pay special 
attention to bias and imprecision. There are no strict 
internationally accepted rules regarding these aspects. 
Over the medically important range analytical goals 
for acceptance are: 1—3% for bias, 0.5— 1.5% for 
within laboratory imprecision and 1 -3%  for between 
laboratory imprecision. In a recent discussion paper of 
a workgroup from the European Quality Assessment 
Organization a further specification is given based on 
the total error concept (14).
In this paper total error is defined as:
CV
Total error (% )  = Bias (% )  H— X tu rn -  n .
Vn
For creatinine the following qualify specifications are 
proposed: ta =  0.025, bias (%) =  0,6%, imprecision 
1.5% and total error (max.) 2.2%.
Our separate results in tables 4, 5 and 6 present a very 
interesting picture. According to the Bilttner cirteria, it 
is clear that all laboratories, except laboratory D, at­
tained the analytical goals. Application of the total error 
concept revealed that all laboratories were successful 
only with the SRM 909a2. For the other materials only 
laboratories A and B showed an adequate score. Most of 
the results show an acceptable imprecision (better than 
1.5%) for all participants,, except sometimes laboratories
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Tab. 6 Summary of the five validated reference sera with respect to the Total error concept.
Material Laboratory Creatinine
mean
C^imol/I]
Absolute bias 
[%]
CV
[%]
Total
error
[%]
Prccinonn U A 165 1.8 0.3 2.0
B 165 1.8 0.3 2,0
C 164 2.4 1.3 3.4
D 164 2.4 3.1 4.8
Mean 164.5 (168) ■ *
Precipath U A 354 Î.4 0.2 1.6
B 358 0.3 1.0 1.1
C 351 2 .2 0.5 2.6
D 351 2 .2 1.9 3.7
Mean 353.5 (359)
RV (German survey) A 219 0.9 0.5 1.3
B 218 1.4 0 .2 1.5
C 217 1.8 1.7 3.1
D 219 0.9 2.3 2.7
MeanI 218.3 (221)
Kontrollogen-L A 122 0 .8 0 .6 1.3
B 123 0 .0 0.9 0.7
C 121 1.6 1.8 3.0
D 121 1.6 3.3 4.1
Mean 121.8 (123)
SRM 909a2 A 462 0 .2 0.5 0 .6
B 463 0 .0 0.9 0.7
C 464 0.2 1.2 1.2
D 463 0 .0 1.3 1.0
Mean 463.0 (463)
Remarks:
1. The column mean is based on 9 measurements.
2, The row mean is the mean o f  all laboratories and is compared 
with the stated values between the brackets.
C and D, while in most cases the bias is higher than a limited batch at the highest technical level for applica-
0.6%. This striking phenomenon leads to the question of tion in very special purposes. We do not know whether
the nature of the specimens used. As far as we know or not this meagre information is sufficient to under-
these were all human serum-based specimens. However, stand the discrepancies we found,
the commercial samples were normal manufacturer-pro- it stresses however once more the crucial importance of 
duced quality control samples provided with reference the required commutability of calibrating and/or control 
method values according to rules of the German Quality material It seems to us that, as a matter of philosophy, 
Assessment Organisation (see Materials and Methods the extent to which a reference method should, in all 
section part 2), while the SRM 909a2 was produced in respects, be matrix robust. Certainly, a reference method
has to be as specific and selective as possible. Should it 
also be able to selectively analyse totally unphysiologi- 
cal specimens? As long as questionable samples (and 
maybe the commercial samples we used belong to this 
categoiy) are not included in a rigorous comparison 
study between a candidate reference method and an ac­
cepted definitive method, final answers to those ques­
tions cannot be given.
Summarizing all results of the main trial, we are of the 
opinion that our method shows good transferability. As 
expected, its application required much attention by the 
participants. We agree that, in particular for laboratory 
D, the imprecision needs improvement, although labora- 
o/ c<\ tory D did meet the quality specification with SRMFig. 2 Graphical presentation o f  the total error % of the five sera J l /  r
in relation to the four participants. 909a2.
Labo­
ratory
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In this respect it is remarkable that the mean values for 
all specimens are so close together and particularly that 
the SRM 909a2 value is extremely correct.
From the results in table 1, it can be seen that the 
SRM 909a2 results in particular differ from each other 
during the periods mentioned. During the years 1991 — 
1995 we used a number of columns in combination 
with different types of ultrafilters while in the period 
1994—1995 we applied the same combination as used 
in the transferability study, i. e. a 5 cm long cation 
exchange column and an ultrafilter with a cut-off value 
of Mr 30 000 both from Bio-Rad. It is clear from this 
example that for a proper choice o f  columns and 
ultrafilters, it is important to use samples like SRM 
909a1 and 909a2.
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